GFACX | MLRSX | GFACX / MLRSX | |
Total Expense Ratio | 1.36 | 0.62 | 219% |
Annual Report Gross Expense Ratio | 1.36 | 0.63 | 216% |
Fund Existence | 24 years | 12 years | - |
Gain YTD | -3.388 | -3.394 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 284B | 12.7B | 2,236% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 0.67 | -4.34 | -15% |
Returns for 3 years | 21.02 | 17.31 | 121% |
Returns for 5 years | 33.68 | 11.18 | 301% |
Returns for 10 years | 43.52 | 7.39 | 589% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLQM | 52.63 | 0.47 | +0.90% |
Franklin US Mid Cap Mltfctr Idx ETF | |||
DWAT | 11.70 | 0.09 | +0.80% |
Arrow DWA Tactical Macro ETF | |||
BIB | 41.56 | 0.30 | +0.73% |
ProShares Ultra Nasdaq Biotechnology | |||
UAPR | 29.95 | 0.02 | +0.07% |
Innovator U.S. Equity Ultra BffrETF™-Apr | |||
HTAB | 18.89 | N/A | N/A |
Hartford Schroders Tax-Aware Bond ETF |